Entia Biosciences Current Ratio vs. Operating Margin
Based on Entia Biosciences' profitability indicators, Entia Biosciences may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in February. Profitability indicators assess Entia Biosciences' ability to earn profits and add value for shareholders.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Please note, there is a significant difference between Entia Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Entia Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Entia Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
For Entia Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Entia Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Entia Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Entia Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Entia Biosciences over time as well as its relative position and ranking within its peers.
Entia |
Entia Biosciences Operating Margin vs. Current Ratio Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Entia Biosciences's current stock value. Our valuation model uses many indicators to compare Entia Biosciences value to that of its competitors to determine the firm's financial worth. Entia Biosciences is one of the top stocks in current ratio category among its peers. It also is one of the top stocks in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Entia Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Entia Biosciences' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Entia Operating Margin vs. Current Ratio
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Entia Biosciences |
| = | 0.11 X |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Entia Biosciences |
| = | (4.40) % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Entia Operating Margin Comparison
Entia Biosciences is currently under evaluation in operating margin category among its peers.
Entia Biosciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Entia Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Entia Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Entia Biosciences' change in net profit over the period of time. It can combine multiple indicators of Entia Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon. Total Nutraceutical operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 6 people.
Entia Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Entia Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Entia Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Entia Biosciences' important profitability drivers and their relationship over time.
Use Entia Biosciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Entia Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entia Biosciences will appreciate offsetting losses from the drop in the long position's value.Entia Biosciences Pair Trading
Entia Biosciences Pair Trading Analysis
The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Entia Biosciences position
In addition to having Entia Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run FinTech Thematic Idea Now
FinTech
High long term potential financial entities that are ranging from payment processing, investment management to commercial and investment banking. The FinTech theme has 69 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize FinTech Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Tools for Entia Pink Sheet
When running Entia Biosciences' price analysis, check to measure Entia Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entia Biosciences is operating at the current time. Most of Entia Biosciences' value examination focuses on studying past and present price action to predict the probability of Entia Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entia Biosciences' price. Additionally, you may evaluate how the addition of Entia Biosciences to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |